Trial intelligence / Profile preview

Biperiden for Post-Traumatic Epilepsy Prevention After TBI

NCT01048138Phase 3Terminated

Sponsor
Federal University of São Paulo
Start
Jan 2018
Primary completion
Dec 2022
Countries
1
01

Overview

A Phase 3 trial of biperiden in post-traumatic epilepsy (PTE), sponsored by Federal University of São Paulo. Started Jan 2018; status: terminated.

02

Drugs

biperiden
03

Conditions

post-traumatic epilepsy (PTE)

Beyond the preview

Go deeper on NCT01048138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01048138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call